US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Perpetuals.com Ltd

3.96

+0.06001.54%

Post-market: 3.77-0.1900-4.80%19:54 EST

Volume:12.19K

Turnover:48.59K

Market Cap:12.08M

PE:-6.64

High:4.09

Open:3.90

Low:3.88

Close:3.90

52wk High:10.50

52wk Low:1.64

Shares:3.05M

Float Shares:1.07M

Volume Ratio:0.05

T/O Rate:1.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5962

EPS(LYR):-0.5960

ROE:-126.84%

ROA:-40.12%

PB:25.65

PE(LYR):-6.64

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Perpetuals.com (NASDAQ: PDC) Completes BayesShield(TM) AI Pilot Demonstrating Loss Reduction in Retail Trading

Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program

Earlyworks Rebrands as Perpetuals.com

Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PDC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","market":"US","secType":"STK","nameCN":"Perpetuals.com Ltd","latestPrice":3.96,"timestamp":1770411600000,"preClose":3.9,"halted":0,"volume":12187,"hourTrading":{"tag":"盘后","latestPrice":3.77,"preClose":3.96,"latestTime":"19:54 EST","volume":857,"amount":3238.245,"timestamp":1770425653967,"change":-0.19,"changeRate":-0.04798,"amplitude":0.049747},"delay":0,"changeRate":0.0153846153846154,"floatShares":1071107,"shares":3050570,"eps":-0.596155,"marketStatus":"Market Closed","change":0.06,"latestTime":"02-06 16:00:00 EST","open":3.9,"high":4.09,"low":3.88,"amount":48591.628603000005,"amplitude":0.053846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.596155,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":5,"listingDate":1690257600000,"exchange":"NASDAQ","adjPreClose":3.9,"preHourTrading":{"tag":"盘前","latestPrice":3.86,"preClose":3.92,"latestTime":"08:26 EST","volume":465,"amount":1803.0200160000002,"timestamp":1770384379967,"change":-0.06,"changeRate":-0.015306,"amplitude":0.05102},"postHourTrading":{"tag":"盘后","latestPrice":3.77,"preClose":3.96,"latestTime":"19:54 EST","volume":857,"amount":3238.245,"timestamp":1770425653967,"change":-0.19,"changeRate":-0.04798,"amplitude":0.049747},"volumeRatio":0.046988487861998884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","floatShares":1071107,"roa":"-40.12%","roe":"-126.84%","lyrEps":-0.596009,"volumeRatio":0.046988487861998884,"shares":3050570,"dividePrice":0,"high":4.09,"amplitude":0.053846,"preClose":3.9,"low":3.88,"week52Low":1.64,"pbRate":"25.65","psRate":"4.31","week52High":10.5,"institutionHeld":0,"latestPrice":3.96,"eps":-0.596155,"divideRate":0,"volume":12187,"delay":0,"ttmEps":-0.596155,"open":3.9,"prevYearClose":6.475,"prevWeekClose":5.04,"prevMonthClose":5.04,"prevQuarterClose":6.475,"fiveDayClose":5.04,"twentyDayClose":6,"sixtyDayClose":4.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-16","symbol":"PDC","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PDC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PDC","date":"2026-02-06","current":-6.642568,"percent":1,"low":-12.841505,"twenty":-12.149167,"median":-9.714799,"eighty":-8.086801,"high":-7.275042,"avg":-9.99483,"sd":1.898063,"marketCap":11897223},"quantilePoints":[{"date":"2026-01-23","current":-12.841505,"twenty":-12.726719,"median":-12.554539,"eighty":-12.382359,"marketCap":20820140},{"date":"2026-01-30","current":-9.396756,"twenty":-12.329049,"median":-11.675543,"eighty":-10.201718,"marketCap":15771446},{"date":"2026-02-06","current":-7.275042,"twenty":-12.149167,"median":-9.714799,"eighty":-8.086801,"marketCap":11897223}],"updateTime":1770468629188},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609516400","title":"Perpetuals.com (NASDAQ: PDC) Completes BayesShield(TM) AI Pilot Demonstrating Loss Reduction in Retail Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2609516400","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609516400?lang=en_us&edition=fundamental","pubTime":"2026-02-07 03:30","pubTimestamp":1770406207,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, February 6th, 2026, FinanceWire Perpetuals.com (NASDAQ: PDC), a regulated financial technology company combining bloc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/perpetuals-com-nasdaq-pdc-completes-bayesshieldtm-ai-pilot-demonstrating-loss-reduction-in-retail-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/perpetuals-com-nasdaq-pdc-completes-bayesshieldtm-ai-pilot-demonstrating-loss-reduction-in-retail-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TM",".IXIC","PDC"],"gpt_icon":0},{"id":"2608873451","title":"Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2608873451","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608873451?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:00","pubTimestamp":1770120000,"startTime":"0","endTime":"0","summary":"Cardiac dosing limit removed and path forward to dose selection identifiedLONDON and PHILADELPHIA, Feb.  03, 2026  (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clini","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/03/3230915/0/en/Avacta-Announces-Two-Key-Clinical-Updates-to-its-Faridoxorubicin-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"gpt_icon":0},{"id":"2606292175","title":"Earlyworks Rebrands as Perpetuals.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2606292175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606292175?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:37","pubTimestamp":1769413024,"startTime":"0","endTime":"0","summary":"Earlyworks Co. Ltd. has completed its acquisition of Perpetual Markets Ltd. and rebranded as Perpetuals.com Ltd., with its Nasdaq ticker symbol now PDC. The company is focusing on integrating blockchain-based solutions for global derivatives trading.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Earlyworks Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL5dvBMC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"gpt_icon":0},{"id":"2605107614","title":"Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605107614","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605107614?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:03","pubTimestamp":1769000580,"startTime":"0","endTime":"0","summary":"The Phase 1 clinical study of FAP-Exd (AVA6103) is anticipated to begin later in Q1 2026 LONDON and PHILADELPHIA, Jan.  21, 2026  (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”, “Av","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/21/3222755/0/en/Avacta-Announces-U-S-Food-and-Drug-Administration-Clearance-of-the-Investigational-New-Drug-IND-Application-for-the-Second-pre-CISION-Medicine-FAP-Exatecan-AVA6103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","PDC"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PDC\",params:#limit:6,delay:false,,,undefined,":[]}}